Medical Properties Trust Beheer
Beheer criteriumcontroles 2/4
De CEO Medical Properties Trust is Ed Aldag, benoemd in Aug2003, heeft een ambtstermijn van 21.25 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 17.85M, bestaande uit 5.6% salaris en 94.4% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.8% van de aandelen van het bedrijf, ter waarde $ 20.37M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7.8 jaar en 8.3 jaar.
Belangrijke informatie
Ed Aldag
Algemeen directeur
US$17.9m
Totale compensatie
Percentage CEO-salaris | 5.6% |
Dienstverband CEO | 21.3yrs |
Eigendom CEO | 0.8% |
Management gemiddelde ambtstermijn | 7.8yrs |
Gemiddelde ambtstermijn bestuur | 8.3yrs |
Recente managementupdates
Recent updates
Medical Properties Trust: Investors Should Be Worried About Liquidity Issues Ahead
Nov 14Medical Properties Trust: Buy The Dip At A 50% Discount To Book Value
Nov 08Medical Properties Trust Q3 Preview: Rare Insider Buy Indicates Improving Sentiment
Oct 29Medical Properties Trust: Why Basket Making Is Important
Oct 21My Biggest Loser List (Part 1): Medical Properties Trust (Rating Downgrade)
Oct 12Medical Properties Trust Bulls Vs. 40%+ Short Interests
Sep 27Medical Properties Trust: The Path To Gains Is Clearer Than Ever
Sep 20Medical Properties Trust Soars On Positive Steward News
Sep 12Upgrading Medical Properties Trust On Possible Bullish Catalyst
Sep 06Medical Properties Trust: Weak Fundamentals And Bearish Technicals Vs. Low Valuations
Aug 27Medical Properties Trust: Cash Flow Concerns Persist
Aug 21Medical Properties Trust Is A Steal At This Price (Upgrade)
Aug 14Medical Properties Trust: Results Incoming
Aug 06Medical Properties Trust: The Endgame Unfolds
Jul 19Medical Properties Trust: Why I Think It Is Worth Having A Pop
Jul 03Medical Properties Trust: The Market Paints A Bright Future - Ignore
Jun 26Medical Properties Trust's Turnaround Is Here - Initiate Cautious Buy
Jun 16Medical Properties Trust: Steward Bankruptcy Exposes Shorts To Squeeze, 11.2% Dividend Yield
Jun 10Medical Properties Trust: Renewed Risks To The Dividend
Jun 02Medical Properties Trust Stock: Mr. Market Is Underestimating This REIT
May 25Medical Properties: Don't Worry About The Steward Bankruptcy
May 12Medical Properties Trust: Don't Celebrate Too Early
May 05Very Good News For Medical Properties Trust
Apr 25Medical Properties Trust: A Key Level Is Now In Sight (Technical Analysis)
Apr 18Medical Properties Trust: No High Rewards Without High Risks (Rating Upgrade)
Apr 11Medical Properties Trust Q4: Wouldn't Touch This REIT With A 10-Foot Pole
Apr 04Medical Properties Trust: Stock Price Is Not Going Anywhere
Mar 18Medical Properties Trust: Downgrading On Another Red Flag
Mar 07Medical Properties Trust: Don't Fall For This Bear Market Rally
Mar 01Medical Properties Trust Q4: No Guidance Causes Uncertainties
Feb 21Confessions Of A Medical Properties Trust Bagholder
Jan 29Lessons From Medical Properties Trust Stock's Implosion
Jan 16Medical Properties Trust: A Cautionary Tale On Reaching For Yield
Jan 08Medical Properties Trust: My Biggest Loser In 2023 (Rating Downgrade)
Jan 02Medical Properties Trust: Dead Money At Best, Better To Avoid
Dec 25Medical Properties Trust: Holding Through Recovery Efforts
Dec 18Medical Properties Trust: Pricey Valuation With Various Downside Risks
Dec 04Sell Medical Properties Trust And Buy These 10%-Yielding Blue Chips Instead
Nov 22Medical Properties Trust: Invest In 12% Yielding Debt Over Shares
Nov 13Medical Properties Trust: The Future Looks Bleak
Nov 02Medical Properties Trust Is Fighting For Its Life
Oct 26Is Medical Properties Trust A Potential Takeover Target?
Oct 20Medical Properties Trust: Why I Am Selling At The Lows And Downgrading To 'Strong Sell'
Oct 11Medical Properties Trust: Sifting Through The Rubble
Oct 01Medical Properties Trust: A Disaster Investors Should Have Seen Coming
Sep 17Medical Properties Trust: The Safest Dividend Is Probably The One That's Just Been Cut (Upgrade)
Aug 29Medical Properties Trust: The Bottom Is In
Aug 22Medical Properties Trust: Dividend Cut Incoming (Downgrade)
Aug 16Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$3b |
Jun 30 2024 | n/a | n/a | -US$2b |
Mar 31 2024 | n/a | n/a | -US$1b |
Dec 31 2023 | US$18m | US$1m | -US$558m |
Sep 30 2023 | n/a | n/a | -US$35m |
Jun 30 2023 | n/a | n/a | US$70m |
Mar 31 2023 | n/a | n/a | US$302m |
Dec 31 2022 | US$16m | US$1m | US$901m |
Sep 30 2022 | n/a | n/a | US$1b |
Jun 30 2022 | n/a | n/a | US$1b |
Mar 31 2022 | n/a | n/a | US$1b |
Dec 31 2021 | US$17m | US$1m | US$654m |
Sep 30 2021 | n/a | n/a | US$558m |
Jun 30 2021 | n/a | n/a | US$517m |
Mar 31 2021 | n/a | n/a | US$512m |
Dec 31 2020 | US$17m | US$1m | US$429m |
Sep 30 2020 | n/a | n/a | US$449m |
Jun 30 2020 | n/a | n/a | US$408m |
Mar 31 2020 | n/a | n/a | US$378m |
Dec 31 2019 | US$17m | US$1m | US$372m |
Sep 30 2019 | n/a | n/a | US$319m |
Jun 30 2019 | n/a | n/a | US$966m |
Mar 31 2019 | n/a | n/a | US$998m |
Dec 31 2018 | US$13m | US$1m | US$1b |
Sep 30 2018 | n/a | n/a | US$1b |
Jun 30 2018 | n/a | n/a | US$349m |
Mar 31 2018 | n/a | n/a | US$311m |
Dec 31 2017 | US$8m | US$950k | US$288m |
Compensatie versus markt: De totale vergoeding ($USD 17.85M ) Ed } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 6.60M ).
Compensatie versus inkomsten: De vergoeding van Ed is gestegen terwijl het bedrijf verliesgevend is.
CEO
Ed Aldag (60 yo)
21.3yrs
Tenure
US$17,854,051
Compensatie
Mr. Edward K. Aldag, Jr., also known as Ed, is a Founder of Medical Properties Trust, Inc. and has been its President and Chief Executive Officer since August 2003. He is President, Chief Executive Officer...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Founder | 21.3yrs | US$17.85m | 0.80% $ 20.4m | |
Founder | 21.2yrs | US$9.11m | 0.45% $ 11.4m | |
Senior VP of Operations & Secretary | no data | US$2.60m | 0.060% $ 1.5m | |
Senior VP | 8.8yrs | US$3.04m | 0.063% $ 1.6m | |
Senior VP & Senior Advisor to the CEO | 1.7yrs | US$3.49m | 0.069% $ 1.8m | |
Managing Director of Investor Relations | no data | geen gegevens | geen gegevens | |
Senior Managing Director of Corporate Communications | 4.4yrs | geen gegevens | geen gegevens | |
VP & Head of Global Acquisitions | no data | geen gegevens | geen gegevens | |
VP, Treasurer & MD of Capital Markets | 6.8yrs | geen gegevens | 0.044% $ 1.1m |
7.8yrs
Gemiddelde duur
57.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van MPW is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.8 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Founder | 20.7yrs | US$17.85m | 0.80% $ 20.4m | |
Founder | 19.8yrs | US$9.11m | 0.45% $ 11.4m | |
Independent Director | 8.3yrs | US$268.16k | 0.0091% $ 231.7k | |
Independent Director | 20.6yrs | US$273.16k | 0.026% $ 650.9k | |
Independent Lead Director | 8.3yrs | US$288.16k | 0.037% $ 938.1k | |
Independent Director | 10.2yrs | US$238.16k | 0.016% $ 408.6k | |
Independent Director | 6.8yrs | US$298.16k | 0.013% $ 325.3k | |
Independent Director | 2.8yrs | US$238.16k | 0.0086% $ 219.2k | |
Independent Director | 4.8yrs | US$268.16k | 0.0094% $ 238.8k |
8.3yrs
Gemiddelde duur
61yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van MPW wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.3 jaar).